Eton Pharmaceuticals, Inc. (ETON) Gross margin 2019–2025
Eton Pharmaceuticals, Inc. (ETON) gross margin by fiscal year — reported gross profit divided by reported revenue.
53.5%FY2025 · since FY2019: 52.8% → 53.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 53.5% | -6.6 pp |
| FY2024 | 60.0% | -6.5 pp |
| FY2023 | 66.6% | -0.8 pp |
| FY2022 | 67.4% | -19.7 pp |
| FY2021 | 87.1% | +1105.0 pp |
| FY2020 | -1017.9% | -1070.7 pp |
| FY2019 | 52.8% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ETON financial trends
ETON RevenueETON Net incomeETON Net marginETON Gross profitETON Operating incomeETON Operating marginETON Operating cash flowETON Free cash flowETON Capital expendituresETON Return on equityETON Stock buybacksETON Dividends paidETON Total assetsETON Total liabilitiesETON Shareholders’ equityETON overview →